(Press-News.org) BEAVERTON, Ore. - New research from Oregon Health & Science University has provided significant insight into the reasons why early-onset puberty occurs in females. The research, which was conducted at OHSU's Oregon National Primate Research Center, is published in the current early online edition of the journal Nature Neuroscience.
The paper explains how OHSU scientists are investigating the role of epigenetics in the control of puberty. Epigenetics refers to changes in gene activity linked to external factors that do not involve changes to the genetic code itself. The OHSU scientists believe improved understanding of these complex protein/gene interactions will lead to greater understanding of both early-onset (precocious) puberty and delayed puberty, and highlight new therapy avenues.
To conduct this research, scientists studied female rats, which like their human counterparts, go through puberty as part of their early aging process. These studies revealed that a group of proteins, called PcG proteins, regulate the activity of a gene called the Kiss1 gene, which is required for puberty to occur. When these PcG proteins diminish, Kiss1 is activated and puberty begins.
PcG proteins are produced by another set of genes that act as a biological switch during the embryonic stage of life. The role of these proteins is to turn off specific downstream genes at key developmental stages.
OHSU scientists found that both the activity of these "master" genes and their ability to turn off puberty are impacted by two forms of epigenetic control: a chemical modification of DNA known as DNA methylation, and changes in the composition of histones, a specialized set of proteins that modify gene activity by interacting with DNA.
Using this new information, researchers were then able to delay puberty in female rats. They accomplished this by increasing PcG protein levels in the hypothalamus of the brain using a targeted gene therapy approach so that Kiss1 activation failed to occur at the normal time in life. The hypothalamus is a region of the brain that controls reproductive development.
"While it was always understood that an organism's genes determine the timing of puberty, the role of epigenetics in this process has never been recorded until now," said Alejandro Lomniczi, Ph.D., a scientist in the Division of Neuroscience at the OHSU Oregon National Primate Research Center.
"Because epigenetic changes are driven by environmental, metabolic and cell-to-cell influences, these findings raise the possibility that a significant percentage of precocious and delayed puberty cases occurring in humans may be the result of environmental factors and other alterations in epigenetic control," said Sergio Ojeda, D.V.M, who is also a scientist in the Division of Neuroscience at the OHSU ONPRC.
"There is also much more to be learned about the way that epigenetic factors may link environmental factors such as nutrition, man-made chemicals, social interactions and other day-today influences to the timing and completion of normal puberty."
###
Collaborators in this research include:
Alberto Loche, Ph.D., a postdoctoral fellow currently at the Friedrich Miescher Institute for Biomedical Research Novartis Research Foundation, Basel, Switzerland
Juan Manuel Castellano, Ph.D., a postdoctoral fellow supported by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme
Hollis Wright, Ph.D., a postdoctoral fellow supported by an NIH Training grant in Reproductive Sciences
Gabi Kaidar, M.D., a postdoctoral fellow currently at Maccabi Health Services, Pardes-Hana, Israel
Oline Ronnekleiv, Ph.D., and Martha Bosh. M.S., at the Department of Physiology and Pharmacology, Oregon Health & Science University, Portland, Ore.
Gerd Pfeiffer, Ph.D., at the Division of Biology, Beckman Research Institute of the City of Hope, Duarte, Calif.
Gabriel Knoll, a graduate student currently at Department of Pediatrics, Oregon Health & Science University, Portland, Ore.
The U.S. National Science Foundation (Grant: IOS1121691) and National Institutes of Health (Grants: HD025123-ARRA and 8P51OD011092) funded this research.
About ONPRC
The ONPRC is a registered research institution, inspected regularly by the United States Department of Agriculture. It operates in compliance with the Animal Welfare Act and has an assurance of regulatory compliance on file with the National Institutes of Health. The ONPRC also participates in the voluntary accreditation program overseen by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC).
About OHSU
Oregon Health & Science University is a nationally prominent research university and Oregon's only public academic health center. It serves patients throughout the region with a Level 1 trauma center and nationally recognized Doernbecher Children's Hospital. OHSU operates dental, medical, nursing and pharmacy schools that rank high both in research funding and in meeting the university's social mission. OHSU's Knight Cancer Institute helped pioneer personalized medicine through a discovery that identified how to shut down cells that enable cancer to grow without harming healthy ones. OHSU Brain Institute scientists are nationally recognized for discoveries that have led to a better understanding of Alzheimer's disease and new treatments for Parkinson's disease, multiple sclerosis and stroke. OHSU's Casey Eye Institute is a global leader in ophthalmic imaging, and in clinical trials related to eye disease.
New OHSU research helps explain early-onset puberty in females
2013-01-29
ELSE PRESS RELEASES FROM THIS DATE:
Tomorrow's life-saving medications may currently be living at the bottom of the sea
2013-01-29
PORTLAND, Ore. – OHSU researchers, in partnership with scientists from several other institutions, have published two new research papers that signal how the next class of powerful medications may currently reside at the bottom of the ocean. In both cases, the researchers were focused on ocean-based mollusks – a category of animal that includes snails, clams and squid and their bacterial companions.
Sea life studies aid researchers in several ways, including the development of new medications and biofuels. Because many of these ocean animal species have existed in ...
Beer's bitter compounds could help brew new medicines
2013-01-29
Researchers employing a century-old observational technique have determined the precise configuration of humulones, substances derived from hops that give beer its distinctive flavor.
That might not sound like a big deal to the average brewmaster, but the findings overturn results reported in scientific literature in the last 40 years and could lead to new pharmaceuticals to treat diabetes, some types of cancer and other maladies.
"Now that we have the right results, what happens to the bitter hops in the beer-brewing process makes a lot more sense," said Werner ...
Annals of Internal Medicine early release article for Jan. 29, 2013
2013-01-29
Philadelphia, January 29, 2012 – The Center for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) announced its recommended 2013 adult immunization schedule that includes important updates to the pneumococcal, Tdap (tetanus, diphtheria, and acellular pertussis), and influenza vaccines. Because current vaccination rates are low, ACIP also urges health care providers to regularly assess patient vaccination histories and implement intervention strategies to increase adherence. This recommendation will be published in Annals of Internal Medicine, ...
Study finds significant microorganism populations in middle and upper troposphere
2013-01-29
In what is believed to be the first study of its kind, researchers used genomic techniques to document the presence of significant numbers of living microorganisms – principally bacteria – in the middle and upper troposphere, that section of the atmosphere approximately four to six miles above the Earth's surface.
Whether the microorganisms routinely inhabit this portion of the atmosphere – perhaps living on carbon compounds also found there – or whether they were simply lofted there from the Earth's surface isn't yet known. The finding is of interest to atmospheric scientists, ...
New research uncovers the neural mechanism underlying drug cravings
2013-01-29
Addiction may result from abnormal brain circuitry in the frontal cortex, the part of the brain that controls decision-making. Researchers from the RIKEN Center for Molecular Imaging Science in Japan collaborating with colleagues from the Montreal Neurological Institute of McGill University in Canada report today that the lateral and orbital regions of the frontal cortex interact during the response to a drug-related cue and that aberrant interaction between the two frontal regions may underlie addiction. Their results are published today in the journal Proceedings of ...
Hospital patient loads often at unsafe levels, physician survey says
2013-01-29
Nationwide, more than one-quarter of hospital-based general practitioners who take over for patients' primary care doctors to manage inpatient care say their average patient load exceeds safe levels multiple times per month, according to a new Johns Hopkins study. Moreover, the study found that one in five of these physicians, known as hospitalists, reports that their workload puts patients at risk for serious complications, or even death.
The research, reported in JAMA Internal Medicine, comes as health care systems anticipate an influx of new patients generated by the ...
Researchers find genes behind aggressive endometrial cancer
2013-01-29
New Haven, Conn. — In a major breakthrough for uterine serous carcinoma (USC) — a chemo-resistant, aggressive form of endometrial cancer, Yale researchers have defined the genetic landscape of USC tumors, findings that point to new treatment opportunities.
The collaborative team—which included researchers with expertise in gynecological cancer, genomics, and computational biology— identified a number of new genes that are frequently mutated in USC. The results of this comprehensive genetic analysis of USC are published in the Jan. 28 Proceedings of the National Academy ...
Slow-release 'jelly' delivers drugs better
2013-01-29
DURHAM, NC -- Duke University biomedical engineers have developed a new delivery system that overcomes the shortcomings of a promising class of peptide drugs – very small proteins – for treating diseases such as diabetes and cancer.
There are more than 40 peptide drugs approved for use in humans and more than 650 are being tested in clinical studies. One example is the hormone insulin, a peptide that regulates the metabolism of carbohydrates in the body and is used as a drug to treat diabetes.
Despite their effectiveness, peptide drugs cannot achieve their full potential ...
Public report national audit of percutaneous coronary interventional procedures 2011
2013-01-29
The 2011 annual report of the National Audit of Percutaneous Coronary Intervention (PCI) highlights the significant progress within hospitals to expand PCI services to treat more patients with acute coronary syndromes.
PCI mechanically improves blood flow to the heart and can be used to relieve the symptoms of angina, prevent and treat heart attacks. When used to treat heart attack patients, the procedure is called primary PCI. Commissioned and funded by the Healthcare Quality Improvement Partnership, the National Audit of PCI is clinically led by the British Cardiovascular ...
Cardiac disease linked to higher risk of mental impairment, Mayo Clinic finds
2013-01-29
ROCHESTER, Minn. -- Cardiac disease is associated with increased risk of mild cognitive impairment such as problems with language, thinking and judgment -- particularly among women with heart disease, a Mayo Clinic study shows. Known as nonamnestic because it doesn't include memory loss, this type of mild cognitive impairment may be a precursor to vascular and other non-Alzheimer's dementias, according to the findings published online Monday in JAMA Neurology.
Mild cognitive impairment is an important stage for early detection and intervention in dementia, says lead author, ...